JW Pharmaceutical Corp operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares JW Pharmaceutical Corp with three other
companies in this sector in South Korea:
Dong A St Co Ltd
sales of 555.03 billion Korean Won [US$515.62 million]
Chongkundang Holdings Corp
(450.74 billion Korean Won [US$418.73 million]
of which 97%
was Medicine), and
Boryung Pharmaceutical Company Limited
(422.72 billion Korean Won [US$392.71 million]
of which 100%
JW Pharmaceutical Corp reported sales of 502.92 billion Korean Won (US$467.21 million)
December of 2017.
increase of 7.6%
versus 2016, when the company's sales were 467.47 billion Korean Won.
This was the fourth straight year of sales growth at JW Pharmaceutical Corp.